Correlation Between Visa and Cathay Biotech

Can any of the company-specific risk be diversified away by investing in both Visa and Cathay Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and Cathay Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Visa Class A and Cathay Biotech, you can compare the effects of market volatilities on Visa and Cathay Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of Cathay Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and Cathay Biotech.

Diversification Opportunities for Visa and Cathay Biotech

0.32

Correlation Coefficient

Visa  Cathay Biotech

Weak diversification

The 3 months correlation between Visa and Cathay is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and Cathay Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cathay Biotech and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with Cathay Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cathay Biotech has no effect on the direction of Visa i.e., Visa and Cathay Biotech go up and down completely randomly.

Pair Corralation between Visa and Cathay Biotech

Taking into account the 90-day investment horizon Visa is expected to generate 2.8 times less return on investment than Cathay Biotech. But when comparing it to its historical volatility, Visa Class A is 3.33 times less risky than Cathay Biotech. It trades about 0.15 of its potential returns per unit of risk. Cathay Biotech is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  3,300  in Cathay Biotech on September 20, 2024 and sell it today you would earn a total of  984.00  from holding Cathay Biotech or generate 29.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	93.65%
Values	Daily Returns

Visa Class A  vs.  Cathay Biotech

Visa Class A

Risk-Adjusted Performance

11 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Visa Class A are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Visa may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Cathay Biotech

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Cathay Biotech are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Cathay Biotech sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Visa and Cathay Biotech

The main advantage of trading using opposite Visa and Cathay Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, Cathay Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cathay Biotech will offset losses from the drop in Cathay Biotech's long position.

The idea behind Visa Class A and Cathay Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.